CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-29 | RAKIN KEVIN Director | Grant or award · Series A Convertible Preferred Stock | −60.07 | $1,000.00 | $60K | 120.15 |
| 2016-09-29 | RAKIN KEVIN Director | Grant or award · Series A Convertible Preferred Stock | −200.25 | $1,000.00 | $200K | 320.39 |
| 2016-09-29 | RAKIN KEVIN Director | Grant or award · Common Stock Warrant (Right to Buy) | −33,333 | 33,333 | ||
| 2016-09-29 | RAKIN KEVIN Director | Grant or award · Common Stock Warrant (Right to Buy) | −33,333 | 66,666 | ||
| 2016-09-29 | RAKIN KEVIN Director | Grant or award · Common Stock Warrant (Right to Buy) | −111,111 | 177,777 | ||
| 2016-09-29 | Wilmslow Estates Ltd 10% owner | Grant or award | +247,665 | $2.25 | $557K | 2,075,331 |
| 2016-09-29 | Wilmslow Estates Ltd 10% owner | Grant or award · Series A Convertible Preferred Stock | −2,242.75 | $1,000.00 | $2.2M | 0 |
| 2016-09-29 | Wilmslow Estates Ltd 10% owner | Grant or award · Common Stock Warrant (Right to Buy) | −1,244,444 | 0 | ||
| 2016-09-29 | Lewis Michael Director | Grant or award | +247,665 | $2.25 | $557K | 2,075,331 |
| 2016-09-29 | Lewis Michael Director | Grant or award · Series A Convertible Preferred Stock | −2,242.75 | $1,000.00 | $2.2M | 0 |
| 2016-09-29 | Lewis Michael Director | Grant or award · Common Stock Warrant (Right to Buy) | −1,244,444 | 0 | ||
| 2016-02-26 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2016-02-26 | Matthews Gloria Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +39,000 | 39,000 | ||
| 2016-02-26 | Kennedy Stephen Richard Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-07-29 | Kennedy Stephen Richard Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2015-07-29 | Matthews Gloria Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2015-07-29 | Matthews Gloria Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2015-07-02 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2015-07-02 | Lieber Jonathan I Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2015-06-24 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 |
Page 23 of 27 · 525 trades